Skip to main content
OpenTrials

Clinical trial condition

Spinal Muscular Atrophies of Childhood

Explore clinical trials studying Spinal Muscular Atrophies of Childhood. Study availability and eligibility vary by location and protocol.

48 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Spinal Muscular Atrophies of Childhood trial results

Completed

Characterization of the Clinical-epidemiological Profile of Patients With SMA5q Types II and III: Observational Study

NCT04404764

Conditions
Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations
  • Universidade Federal de Minas Gerais - Hospital das Clínicas Belo Horizonte, Brazil
  • Hospital de Clínicas da Universidade Estadual de Campinas - Unicamp Campinas, Brazil
  • Associação Hospitalar de Prot Infancia Dr Raul Carneiro - Hospital Infantil Pequeno Príncipe Curitiba, Brazil
  • Hospital Infantil Dr. Albert Sabin Fortaleza, Brazil
View Trial Details
Completed

International SMA Patient Registry

NCT00466349

Conditions
Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +8 more
Locations
  • Indiana University School of Medicine Indianapolis, Indiana, United States
View Trial Details
Completed

Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy

NCT02391831

Conditions
Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +10 more
Locations
  • Reference centre for neuromuscular diseases - UZ Leuven - Department of Pediatrics - University Hospitals Leuven Leuven, Belgium
  • Centre de Référence neuromusculaire - CHR La Citadelle Liège, Belgium
  • Service de Rééducation Pédiatrique Infantile " L'Escale " - Hôpital Femme Mère Enfant Bron, France
  • Maladie Neuromusculaire de l'enfant - Service Maladies infectieuses et neurologie infantile - Hôpital Roger Salengro Lille, France
View Trial Details
Completed

Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.

NCT01302600

Conditions
Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +10 more
Locations
  • University Hospitals Ghent, Belgium
  • University Hospitals Leuven, Belgium
  • Hôpital Femme-Mère-Enfant Bron, France
  • Hôpital Raymond Poincaré Garches, France
View all 22 locations
View Trial Details
Completed

CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I

NCT00661453

Conditions
Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Children's Hospital of Michigan Detroit, Michigan, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Ohio State University Medical Center, Dept. of Neurology Columbus, Ohio, United States
View Trial Details
Completed

Pilot Study of Growth Hormon to Treat SMA Typ II and III

NCT00533221

Conditions
Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +8 more
Locations
  • von Haunersches Kinderspital Munich, Bavaria, Germany
  • University Children'S Hospital Göttingen, Lower Saxony, Germany
  • University Children'S Hospital Essen, North Rhine-Westphalia, Germany
  • University Children'S Hospital Mainz, Rhineland-Palatinate, Germany
View Trial Details

Related conditions